Wendy Diller

Senior Writer/Market Analyst

20 Years of Experience

About

Wendy writes on the medical devices and clinical diagnostics sectors, where she focuses on orthopedics/spine, molecular diagnostics and personalized medicine, clinical genomics, womens’ health/ femtech, and reimbursement/commercial strategy and innovation related to these specialties. She welcomes and encourages ideas and input from members of the MedTech Strategist Community.

Her career spans more than 20+ years as a top writer and manager focused on qualitative analysis of the global life sciences industry. She is Chair of Young Women in Bio Metro NY, an organization devoted to encouraging secondary students in the NY area to pursuit STEM careers and on the board of the Columbia Business School of Alumni Club NY

Specialties
Publications
Articles from Wendy Diller:
Read all from this author
Business Strategies

Pacira’s Fight for the NoPain Act: Device Manufacturers Gain, Too

  • January 23, 2025
  • Wendy Diller
  • MedTech Strategist

The Non-Opioids Prevent Addiction in the Nation Act (NOPAIN Act) went into effect on January 1, 2025, improving reimbursement for non-opioid drug and device analgesics in the hospital outpatient and ambulatory surgery center settings. It was the culmination of years of work on Capitol Hill by a coalition led by a small biotech company, Pacira Biosciences.

Read Article